Cationic Albumin‐Conjugated Chelating Agent as a Novel Brain Drug Delivery System in Neurodegeneration

Publisher: John Wiley & Sons Inc

E-ISSN: 1747-0285|86|5|1203-1214

ISSN: 1747-0277

Source: CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol.86, Iss.5, 2015-11, pp. : 1203-1214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract